Skip to main content

Closed

DWTX: Dogwood Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-30.9%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage0.0×

Current ratio5.86×

Dogwood Therapeutics, Inc.

DWTXNASDAQ Capital Market·USD·Closed

Dogwood Therapeutics, Inc.

DWTXNASDAQ·USD·Closed

$1.64

+3.80%

$1.64

+$0.06 (3.80%)

52W Range

4thpctl

Volume

0.58×avg

Mkt Cap

3.13MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.58×avg

Market Cap

3.13MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings